テネシーにおける慢性腎臓病の臨床試験
テネシー内の拠点で、慢性腎臓病に関する14件の研究が参加者を募集しています。
テネシー内の都市
公式研究テキスト（英語）
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #4, Chattanooga
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07268638A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Chattanooga
- Research Site, Knoxville
- Research Site, Knoxville
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06742723A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Research Site, Chattanooga
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/24更新 · NCT07624305Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- University of Tennessee Health Science Center- Le Bonheur Research Center, Memphis
被験者募集中第3相
2歳〜18歳 · 全性別 · 2026/09/21更新 · NCT07498335A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- Vanderbilt University Medical Center, Nashville
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/16更新 · NCT07107945Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Southeast Renal Research Institute, Chattanooga
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/11更新 · NCT07271186A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Research Site, Morristown
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07753993Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
- Memphis VA Medical Center, Memphis, TN, Memphis
被験者募集中
18歳以上 · 全性別 · 2026/08/20更新 · NCT05465044Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Knoxville Kidney Center Pllc, Brentwood
被験者募集中第3相
18歳〜100歳 · 全性別 · 2026/08/17更新 · NCT06858319Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- Vanderbilt University Medical Center, Nashville
被験者募集中第2相
21歳〜85歳 · 全性別 · 2026/05/06更新 · NCT04984226Empagliflozin Treatment in Kidney Transplant Recipients
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
被験者募集中第4相
19歳以上 · 全性別 · 2026/04/21更新 · NCT06013865Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage
- Vanderbilt University Medical Center, Nashville
被験者募集中
18歳以上 · 全性別 · 2026/04/06更新 · NCT07385651SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- James Eric Gardner, MD, PC, Memphis
被験者募集中
18歳以上 · 全性別 · 2026/02/17更新 · NCT06001827Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
- University of Tennessee Medical Center, Knoxville
- University of Tennessee Health Science Center/Regional One Health, Memphis
被験者募集中
18歳以上 · 全性別 · 2026/01/29更新 · NCT06374277ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。